- Illustrations
- Specialized Illustrations
- Disease-specific
- Focal Adenomyoma (Uterine Myometrium)
Focal Adenomyoma (Uterine Myometrium)
A focal adenomyoma within the uterine myometrium, presenting as a localized nodule within the muscular wall.
jpg, png
exc.VAT*
Prices are displayed excluding VAT. VAT will be calculated during checkout based on your business location and VAT number validity.
Description
Uterine wall anatomy frames a focal adenomyoma embedded in the myometrium as a discrete, rounded nodule. The lesion sits deep to the serosal surface and superficial to the endometrium, compressing adjacent smooth muscle bundles while remaining confined within the muscular coat. A cutaway concept is implied by the visibility of layered uterine architecture, with the endometrial cavity positioned medial to the mass and the perimetrium forming the outer contour. Borders appear more localized than diffuse adenomyosis. Focal adenomyoma matters because it sits at the intersection of benign myometrial tumors and ectopic endometrial tissue, and it often enters the differential diagnosis for intramural leiomyoma on ultrasound and MRI. Clinically, patients may present with dysmenorrhea, deep pelvic pain, and heavy menstrual bleeding, and the lesion’s proximity to the endometrial cavity can help explain abnormal uterine bleeding when the junctional zone is distorted. The fixed perspective supports teaching of wall-layer relationships, emphasizing how an adenomyoma can remain intramural while still influencing uterine contour and cavity geometry. Use this illustration in gynecologic pathology lectures to contrast focal adenomyoma with leiomyoma and diffuse adenomyosis, or in radiology teaching files when correlating an intramural nodule with junctional zone thickening on T2-weighted MRI. It also fits operative planning discussions for adenomyomectomy or hysterectomy, where the relationship of the nodule to serosa and endometrium guides myometrial incision depth and cavity entry risk. Anatomical accuracy verified by SciePro's Medical Advisory Board.